Innovation for Health - 15-16 April 2021
Innovation for Health - Shaping the future of healthcare

Thomas Hankemeier

Professor of Analytical biosciences, LACDR, Leiden University

Thomas Hankemeier is full professor of Analytical BioSciences at the LACDR, Leiden University, since 2004. He leads as principal investigator the Analytical BioSciences and Metabolomics group, and he is the chair of the new Division of Systems Biomedicine and Pharmacology. His research is aiming at innovative analytical tools for metabolomics-driven systems biology in personalized health strategies. In collaboration with clinicians, biomedical researchers, biostatisticians and other –omics researchers he works on better (early) diagnosis and interventions for (cardio)vascular and metabolic diseases and neurological diseases. His ultimate goal is to identify early disease pathways and network changes that can be modulated by interventions to prevent or treat diseases, and support the development of novel intervention strategies to prevent or treat diseases. He is reaching out to cooperate with industry within a fieldlab MXL to develop companion diagnostics, early discovering of side effects in clinical trials, and evaluation methods of medicine treatment per patient.
Jan van de Winkel
Eline Vrijland-van Beest
Hybridize Therapeutics

Carmen van Vilsteren
Topsector Life Science & Health

Tim Van Hauwermeiren 

Antoon van Oosterhout
Imyse SA
Willem Mulder
Jolanda M. de Vries
Yvette van Kooyk
Amsterdam UMC
Ronald Plasterk
Frame Cancer Therapeutics
Paul WG Elbers
Amsterdam UMC
Prof. Dr. Ing. Ron A.M. Fouchier
Erasmus MC
Sponsors & Partners 2021
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Main Virtual Conference sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Powered by
Hyphen Projects
© 2020 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.
By continuing to use this site, you consent to our use of cookies. For more information, read: